Amanta Healthcare share news, announcements and annual reports
NSE: AMANTABSE: 544502Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹160.34.
29 Oct: open ₹161.01, high ₹178.57, low ₹161.01
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹664 Cr1,889th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 45.21
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹2.63 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 38.34
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 6.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹2.63 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 7.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.06
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,55,847
Amanta Healthcare has 150 announcements on record, routine notices left out; 8 in the 30 days to 29 Oct 2026, the latest on 26 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Amanta Healthcare quarterly results
The board meets on 3 Nov 2026 to consider financial results
Notice filed 26 Oct 2026
To consider and approve the financial results for the quarter and half year ended September 30, 2026
Amanta Healthcare annual reports, presentations and earnings calls
The company's own documents, latest first.Amanta Healthcare financials, year by year
Annual reports1
- Annual report, year to Mar 202624 Aug 2026
Investor presentations3
- Investor Presentation5 Aug 2026
- Investor Presentation19 May 2026
- Investor Presentation11 Feb 2026
Earnings calls6
- Transcript8 Aug 2026
- Link of Recording6 Aug 2026
- Transcript21 May 2026
- Link of Recording19 May 2026
- Transcript16 Feb 2026
1 earlier call document
- Link of Recording11 Feb 2026
Amanta Healthcare share news and announcements
Newest first. Page 1 of 3.
Oct 2026
Sep 2026
16 Sep · Meeting
16 Sep · Management
16 Sep · Management
16 Sep · Meeting
16 Sep · Meeting
3 Sep · Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
2 Sep · General Updates
Aug 2026
25 Aug · General Updates
8 Aug · Business
8 Aug · Business
7 Aug · General Updates
5 Aug · Business
5 Aug · General Updates
5 Aug · Results
5 Aug · Board meeting
5 Aug · Management
3 Aug · Analysts
Jul 2026
29 Jul · Board meeting
9 Jul · Analysts
6 Jul · Analysts
6 Jul · Analysts
Jun 2026
29 Jun · General Updates
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 17 Sep 2026Board or managers changedup 0.01%−0.5 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−2.2 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 6 Aug 2026Board or managers changeddown 2.00%−2.0 pts vs Nifty 500market median 0.0% · five sessions −9.6% (−9.3 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 6 Aug 2026Resultsdown 2.00%−2.0 pts vs Nifty 500market median −0.7% · five sessions −9.6% (−9.3 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 20 May 2026Resultsdown 4.54%−4.8 pts vs Nifty 500market median −0.7% · five sessions +0.7% (−1.0 pts vs Nifty 500) · volume 0.7× usual · delivery −5.8 pts against usual · The announcement
- 16 Apr 2026Board or managers changedup 6.31%+6.0 pts vs Nifty 500market median 0.0% · five sessions +12.1% (+10.4 pts vs Nifty 500) · volume 8.8× usual · delivery −26.6 pts against usual · The announcement
- 17 Feb 2026Credit ratingup 5.12%+4.8 pts vs Nifty 500market median 0.0% · five sessions +1.2% (+1.1 pts vs Nifty 500) · volume 4.8× usual · delivery +18.9 pts against usual · The announcement
- 10 Feb 2026Board or managers changedup 0.84%+0.5 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−1.9 pts vs Nifty 500) · volume 1.2× usual · delivery −4.5 pts against usual · The announcement
- 10 Feb 2026Resultsup 0.84%+0.5 pts vs Nifty 500market median −0.7% · five sessions −2.8% (−1.9 pts vs Nifty 500) · volume 1.2× usual · delivery −4.5 pts against usual · The announcement
- 12 Nov 2025Resultsdown 0.37%−1.0 pts vs Nifty 500market median −0.7% · five sessions −2.9% (−3.5 pts vs Nifty 500) · volume 0.5× usual · delivery −5.7 pts against usual · The announcement
- 29 Sep 2025Resultsup 1.35%+1.2 pts vs Nifty 500market median −0.7% · five sessions −0.3% (−2.3 pts vs Nifty 500) · The announcement
Amanta Healthcare results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Tax | Quarter to Sep 2025 | Standalone | 1.07 | 1.07 | 0.0% | 12 Jan 2026 | 27 May 2026 |
| Net profit | Quarter to Sep 2025 | Standalone | 1.21 | 1.21 | 0.0% | 12 Jan 2026 | 27 May 2026 |
| Current tax | Quarter to Sep 2025 | Standalone | 1.97 | 1.97 | 0.0% | 12 Jan 2026 | 27 May 2026 |
| Net profit from continuing businesses | Quarter to Sep 2025 | Standalone | 1.21 | 1.21 | 0.0% | 12 Jan 2026 | 27 May 2026 |
| Total comprehensive income | Quarter to Sep 2025 | Standalone | 1.11 | 1.11 | 0.0% | 12 Jan 2026 | 27 May 2026 |
| Change in other current financial assets | Year to date to Sep 2025 | Standalone | −0.15 | −0.27 | −84.4% | 11 Nov 2025 | 12 Jan 2026 |
| Change in other current liabilities | Year to date to Sep 2025 | Standalone | 0.51 | 2.53 | +393.6% | 11 Nov 2025 | 12 Jan 2026 |
| Other adjustments from profit to cash | Year to date to Sep 2025 | Standalone | 2.49 | 2.63 | +5.4% | 11 Nov 2025 | 12 Jan 2026 |
| Adjustments from profit to cash | Year to date to Sep 2025 | Standalone | 21.31 | 23.03 | +8.1% | 11 Nov 2025 | 12 Jan 2026 |
| Cash generated before tax | Year to date to Sep 2025 | Standalone | 28.51 | 30.23 | +6.0% | 11 Nov 2025 | 12 Jan 2026 |